Elevated platelet distribution width predicts poor prognosis in hepatocellular carcinoma

被引:25
|
作者
Zuo, Xiaomin [1 ]
Kong, Weihao [2 ]
Feng, Linfei [3 ]
Zhang, Huabing [4 ]
Meng, Xiangling [1 ]
Chen, Wei [1 ]
机构
[1] Anhui Med Univ, Affiliated Hosp 1, Dept Gen Surg, 218 Jixi Ave, Hefei 230032, Anhui, Peoples R China
[2] Anhui Med Univ, Affiliated Hosp 1, Dept Emergency Med, Dept Emergency Surg, Hefei, Anhui, Peoples R China
[3] Anhui Med Univ, Affiliated Hosp 1, Dept Oral & Maxillofacial Surg, Hefei, Anhui, Peoples R China
[4] Anhui Med Univ, Sch Basic Med, Dept Biochem & Mol Biol, Hefei, Anhui, Peoples R China
基金
中国国家自然科学基金;
关键词
Platelet distribution width; hepatocellular carcinoma; prognosis; CANCER; COUNT; METASTASIS; VOLUME;
D O I
10.3233/CBM-182076
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Previous studies have demonstrated that platelets play an important role in growth, invasion, and angiogenesis of a variety of tumors. Nevertheless, the prognostic role of platelet indices in hepatocellular carcinoma (HCC) has not been explored. The aim of this study was to explore the association between platelet indices and prognosis in HCC. METHOD: A total of 260 patients with HCC between January 2009 and December 2015 were retrospectively analyzed. The optimal platelet distribution width (PDW) cutoff value is identified by the receiver operating characteristic curve (ROC) curve. The relationship between PDW and clinicopathological features was assessed. The prognostic effects of PDW were assessed by using the Kaplan-Meier method and Cox regression model. RESULT: Elevated PDW level was significantly associated with portal hypertension, vascular invasion, and Child-Pugh grade. In addition, survival curve indicates that patients with high PDW levels have a worse prognosis than patients with low PDW levels (P < 0.001). Multivariate Cox regression analysis identified PDW as an independent factor of prognosis in HCC patients (hazard ratio: 4.460, 95% confidence interval: 2.308-8.619, P < 0.001). CONCLUSION: Elevated PDW may be a novel marker for predicting the prognosis of HCC, but further research is needed to validate our conclusions.
引用
收藏
页码:307 / 313
页数:7
相关论文
共 50 条
  • [31] Elevated Preoperative Serum Gamma-glutamyltranspeptidase Predicts Poor Prognosis for Hepatocellular Carcinoma after Liver Transplantation
    Shun-Jun Fu
    Qiang Zhao
    Fei Ji
    Mao-Gen Chen
    Lin-Wei Wu
    Qing-Qi Ren
    Zhi-Yong Guo
    Xiao-Shun He
    [J]. Scientific Reports, 6
  • [32] Elevated neutrophil to lymphocyte ratio predicts poor prognosis in nasopharyngeal carcinoma
    An, Xin
    Ding, Pei-Rong
    Wang, Feng-Hua
    Jiang, Wen-Qi
    Li, Yu-Hong
    [J]. TUMOR BIOLOGY, 2011, 32 (02) : 317 - 324
  • [33] Expression of prothymosin α predicts early recurrence and poor prognosis of hepatocellular carcinoma
    Ha, Sang Yun
    Song, Dae Hyun
    Hwang, Soo Hyun
    Cho, Soo Youn
    Park, Cheol-Keun
    [J]. HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2015, 14 (02) : 171 - 177
  • [34] Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients
    Lu He
    Xinke Zhou
    Chen Qu
    Yunqiang Tang
    Qiong Zhang
    Jian Hong
    [J]. Medical Oncology, 2013, 30
  • [35] CCL15 overexpression predicts poor prognosis for hepatocellular carcinoma
    Li, YueGuo
    Yu, Hai Peng
    Zhang, Peng
    [J]. HEPATOLOGY INTERNATIONAL, 2016, 10 (03) : 488 - 492
  • [36] Scinderin suppresses cell proliferation and predicts the poor prognosis of hepatocellular carcinoma
    Zhou, Bin
    Chen, Tian-Wei
    Jiang, Ya-Bo
    Wei, Xu-Biao
    Lu, Chong-De
    Li, Jing-Jing
    Xie, Dong
    Cheng, Shu-Qun
    [J]. ONCOLOGY LETTERS, 2020, 19 (03) : 2011 - 2020
  • [37] Overexpression of RALY promotes migration and predicts poor prognosis in hepatocellular carcinoma
    Zhu, Zebin
    Zhang, Yixi
    Huang, Chensong
    Tang, Yunhua
    Sun, Chengjun
    Ju, Weiqiang
    He, Xiaoshun
    [J]. CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 5559 - 5572
  • [38] Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients
    He, Lu
    Zhou, Xinke
    Qu, Chen
    Tang, Yunqiang
    Zhang, Qiong
    Hong, Jian
    [J]. MEDICAL ONCOLOGY, 2013, 30 (04)
  • [39] Methylation of PCDH19 predicts poor prognosis of hepatocellular carcinoma
    Zhang, Ting
    Guan, Guiwen
    Chen, Tingting
    Jin, Jingling
    Zhang, Lichun
    Yao, Mingjie
    Qi, Xuewei
    Zou, Jun
    Chen, Jiacheng
    Lu, Fengmin
    Chen, Xiangmei
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 (05) : e352 - e358
  • [40] Expression of prothymosin α predicts early recurrence and poor prognosis of hepatocellular carcinoma
    Sang Yun Ha
    Dae Hyun Song
    Soo Hyun Hwang
    Soo Youn Cho
    Cheol-Keun Park
    [J]. Hepatobiliary & Pancreatic Diseases International, 2015, 14 (02) : 171 - 177